| 3′UTR | 3′untranslated region |
| ALL | acute lymphoblastic leukemia |
| AML | Acute myeloid leukemia |
| BAALC | brain and acute lymphoblastic leukemia |
| BCP-ALL | B-cell precursor acute lymphoblastic leukemia |
| CKD6 | cyclin dependent kinase 6 |
| DFR | disease free of recurrence |
| DFS | disease-free survival |
| DR | downregulation |
| EGIL | The European Group for the Immunologic Classification |
| ETP-ALL | Early T-cell precursor ALL |
| GRα | glucocorticoid receptor alpha |
| GSI | γ-secretase inhibitors |
| JAK | Janus kinase |
| LBL | lymphoblastic lymphoma |
| miRNA | MicroRNA |
| MMP9 | metalloproteinase 9 |
| MRD | minimal residual disease |
| OE | overexpression |
| OS | overall survival |
| PBMNC | peripheral blood mononuclear cells |
| PDGF | Platelet Derived Growth Factor |
| RB1 | retinoblastoma protein |
| RFS | relapse-free survival |
| shRNA | short hairpin RNA |
| STK39 | serine/threonine kinase 39 |
| T-ALL | T-cell acute lymphoblastic leukemia |
| TLX | T-cell leukemia homeobox 1 |
| TLX3 | homeobox 3 |